Next-Generation Biologics Market Report

China Next-Generation Biologics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 21, 2022
  • PAGES：226
  • REPORT CODE：GMM1054783
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Next-Generation Biologics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Next-Generation Biologics market. Detailed analysis of key players, along with key growth strategies adopted by Next-Generation Biologics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Pfizer

    • Eli Lilly

    • Molecular Partners

    • Novo Nordisk

    • Allergan

    • Bayer

    • Kyowa Hakko Kirin

    • Roche

    • Biogen Idec

    • Sanofi

    By Type:

    • Antibodies

    • Regenerative medicine

    • Insulins

    • Growth hormones

    • Other

    By End-User:

    • Medical

    • Scientific Research

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Next-Generation Biologics Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Next-Generation Biologics Market Size and Growth Rate of Antibodies from 2016 to 2027

    • 1.3.2 China Next-Generation Biologics Market Size and Growth Rate of Regenerative medicine from 2016 to 2027

    • 1.3.3 China Next-Generation Biologics Market Size and Growth Rate of Insulins from 2016 to 2027

    • 1.3.4 China Next-Generation Biologics Market Size and Growth Rate of Growth hormones from 2016 to 2027

    • 1.3.5 China Next-Generation Biologics Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Next-Generation Biologics Market Size and Growth Rate of Medical from 2016 to 2027

    • 1.4.2 China Next-Generation Biologics Market Size and Growth Rate of Scientific Research from 2016 to 2027

    • 1.4.3 China Next-Generation Biologics Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Next-Generation Biologics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Next-Generation Biologics by Major Types

    • 3.4.1 Market Size and Growth Rate of Antibodies

    • 3.4.2 Market Size and Growth Rate of Regenerative medicine

    • 3.4.3 Market Size and Growth Rate of Insulins

    • 3.4.4 Market Size and Growth Rate of Growth hormones

    • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Next-Generation Biologics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Next-Generation Biologics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Next-Generation Biologics in Medical

    • 4.4.2 Market Size and Growth Rate of Next-Generation Biologics in Scientific Research

    • 4.4.3 Market Size and Growth Rate of Next-Generation Biologics in Other

    5 Market Analysis by Regions

    • 5.1 China Next-Generation Biologics Production Analysis by Regions

    • 5.2 China Next-Generation Biologics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Next-Generation Biologics Landscape Analysis

    • 6.1 North China Next-Generation Biologics Landscape Analysis by Major Types

    • 6.2 North China Next-Generation Biologics Landscape Analysis by Major End-Users

    7 Central China Next-Generation Biologics Landscape Analysis

    • 7.1 Central China Next-Generation Biologics Landscape Analysis by Major Types

    • 7.2 Central China Next-Generation Biologics Landscape Analysis by Major End-Users

    8 South China Next-Generation Biologics Landscape Analysis

    • 8.1 South China Next-Generation Biologics Landscape Analysis by Major Types

    • 8.2 South China Next-Generation Biologics Landscape Analysis by Major End-Users

    9 East China Next-Generation Biologics Landscape Analysis

    • 9.1 East China Next-Generation Biologics Landscape Analysis by Major Types

    • 9.2 East China Next-Generation Biologics Landscape Analysis by Major End-Users

    10 Northeast China Next-Generation Biologics Landscape Analysis

    • 10.1 Northeast China Next-Generation Biologics Landscape Analysis by Major Types

    • 10.2 Northeast China Next-Generation Biologics Landscape Analysis by Major End-Users

    11 Southwest China Next-Generation Biologics Landscape Analysis

    • 11.1 Southwest China Next-Generation Biologics Landscape Analysis by Major Types

    • 11.2 Southwest China Next-Generation Biologics Landscape Analysis by Major End-Users

    12 Northwest China Next-Generation Biologics Landscape Analysis

    • 12.1 Northwest China Next-Generation Biologics Landscape Analysis by Major Types

    • 12.2 Northwest China Next-Generation Biologics Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Pfizer

      • 13.1.1 Pfizer Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Eli Lilly

      • 13.2.1 Eli Lilly Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Molecular Partners

      • 13.3.1 Molecular Partners Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Novo Nordisk

      • 13.4.1 Novo Nordisk Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Allergan

      • 13.5.1 Allergan Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Bayer

      • 13.6.1 Bayer Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Kyowa Hakko Kirin

      • 13.7.1 Kyowa Hakko Kirin Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Roche

      • 13.8.1 Roche Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Biogen Idec

      • 13.9.1 Biogen Idec Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Sanofi

      • 13.10.1 Sanofi Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Next-Generation Biologics Market Size and Growth Rate of Antibodies from 2016 to 2027

    • Figure China Next-Generation Biologics Market Size and Growth Rate of Regenerative medicine from 2016 to 2027

    • Figure China Next-Generation Biologics Market Size and Growth Rate of Insulins from 2016 to 2027

    • Figure China Next-Generation Biologics Market Size and Growth Rate of Growth hormones from 2016 to 2027

    • Figure China Next-Generation Biologics Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Next-Generation Biologics Market Size and Growth Rate of Medical from 2016 to 2027

    • Figure China Next-Generation Biologics Market Size and Growth Rate of Scientific Research from 2016 to 2027

    • Figure China Next-Generation Biologics Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Next-Generation Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Next-Generation Biologics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Next-Generation Biologics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Next-Generation Biologics by Different Types from 2016 to 2027

    • Table Consumption Share of Next-Generation Biologics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Antibodies

    • Figure Market Size and Growth Rate of Regenerative medicine

    • Figure Market Size and Growth Rate of Insulins

    • Figure Market Size and Growth Rate of Growth hormones

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Next-Generation Biologics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Next-Generation Biologics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Medical

    • Figure Market Size and Growth Rate of Scientific Research

    • Figure Market Size and Growth Rate of Other

    • Table China Next-Generation Biologics Production by Regions

    • Table China Next-Generation Biologics Production Share by Regions

    • Figure China Next-Generation Biologics Production Share by Regions in 2016

    • Figure China Next-Generation Biologics Production Share by Regions in 2021

    • Figure China Next-Generation Biologics Production Share by Regions in 2027

    • Table China Next-Generation Biologics Consumption by Regions

    • Table China Next-Generation Biologics Consumption Share by Regions

    • Figure China Next-Generation Biologics Consumption Share by Regions in 2016

    • Figure China Next-Generation Biologics Consumption Share by Regions in 2021

    • Figure China Next-Generation Biologics Consumption Share by Regions in 2027

    • Table North China Next-Generation Biologics Consumption by Types from 2016 to 2027

    • Table North China Next-Generation Biologics Consumption Share by Types from 2016 to 2027

    • Figure North China Next-Generation Biologics Consumption Share by Types in 2016

    • Figure North China Next-Generation Biologics Consumption Share by Types in 2021

    • Figure North China Next-Generation Biologics Consumption Share by Types in 2027

    • Table North China Next-Generation Biologics Consumption by End-Users from 2016 to 2027

    • Table North China Next-Generation Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure North China Next-Generation Biologics Consumption Share by End-Users in 2016

    • Figure North China Next-Generation Biologics Consumption Share by End-Users in 2021

    • Figure North China Next-Generation Biologics Consumption Share by End-Users in 2027

    • Table Central China Next-Generation Biologics Consumption by Types from 2016 to 2027

    • Table Central China Next-Generation Biologics Consumption Share by Types from 2016 to 2027

    • Figure Central China Next-Generation Biologics Consumption Share by Types in 2016

    • Figure Central China Next-Generation Biologics Consumption Share by Types in 2021

    • Figure Central China Next-Generation Biologics Consumption Share by Types in 2027

    • Table Central China Next-Generation Biologics Consumption by End-Users from 2016 to 2027

    • Table Central China Next-Generation Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Next-Generation Biologics Consumption Share by End-Users in 2016

    • Figure Central China Next-Generation Biologics Consumption Share by End-Users in 2021

    • Figure Central China Next-Generation Biologics Consumption Share by End-Users in 2027

    • Table South China Next-Generation Biologics Consumption by Types from 2016 to 2027

    • Table South China Next-Generation Biologics Consumption Share by Types from 2016 to 2027

    • Figure South China Next-Generation Biologics Consumption Share by Types in 2016

    • Figure South China Next-Generation Biologics Consumption Share by Types in 2021

    • Figure South China Next-Generation Biologics Consumption Share by Types in 2027

    • Table South China Next-Generation Biologics Consumption by End-Users from 2016 to 2027

    • Table South China Next-Generation Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure South China Next-Generation Biologics Consumption Share by End-Users in 2016

    • Figure South China Next-Generation Biologics Consumption Share by End-Users in 2021

    • Figure South China Next-Generation Biologics Consumption Share by End-Users in 2027

    • Table East China Next-Generation Biologics Consumption by Types from 2016 to 2027

    • Table East China Next-Generation Biologics Consumption Share by Types from 2016 to 2027

    • Figure East China Next-Generation Biologics Consumption Share by Types in 2016

    • Figure East China Next-Generation Biologics Consumption Share by Types in 2021

    • Figure East China Next-Generation Biologics Consumption Share by Types in 2027

    • Table East China Next-Generation Biologics Consumption by End-Users from 2016 to 2027

    • Table East China Next-Generation Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure East China Next-Generation Biologics Consumption Share by End-Users in 2016

    • Figure East China Next-Generation Biologics Consumption Share by End-Users in 2021

    • Figure East China Next-Generation Biologics Consumption Share by End-Users in 2027

    • Table Northeast China Next-Generation Biologics Consumption by Types from 2016 to 2027

    • Table Northeast China Next-Generation Biologics Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Next-Generation Biologics Consumption Share by Types in 2016

    • Figure Northeast China Next-Generation Biologics Consumption Share by Types in 2021

    • Figure Northeast China Next-Generation Biologics Consumption Share by Types in 2027

    • Table Northeast China Next-Generation Biologics Consumption by End-Users from 2016 to 2027

    • Table Northeast China Next-Generation Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Next-Generation Biologics Consumption Share by End-Users in 2016

    • Figure Northeast China Next-Generation Biologics Consumption Share by End-Users in 2021

    • Figure Northeast China Next-Generation Biologics Consumption Share by End-Users in 2027

    • Table Southwest China Next-Generation Biologics Consumption by Types from 2016 to 2027

    • Table Southwest China Next-Generation Biologics Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Next-Generation Biologics Consumption Share by Types in 2016

    • Figure Southwest China Next-Generation Biologics Consumption Share by Types in 2021

    • Figure Southwest China Next-Generation Biologics Consumption Share by Types in 2027

    • Table Southwest China Next-Generation Biologics Consumption by End-Users from 2016 to 2027

    • Table Southwest China Next-Generation Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Next-Generation Biologics Consumption Share by End-Users in 2016

    • Figure Southwest China Next-Generation Biologics Consumption Share by End-Users in 2021

    • Figure Southwest China Next-Generation Biologics Consumption Share by End-Users in 2027

    • Table Northwest China Next-Generation Biologics Consumption by Types from 2016 to 2027

    • Table Northwest China Next-Generation Biologics Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Next-Generation Biologics Consumption Share by Types in 2016

    • Figure Northwest China Next-Generation Biologics Consumption Share by Types in 2021

    • Figure Northwest China Next-Generation Biologics Consumption Share by Types in 2027

    • Table Northwest China Next-Generation Biologics Consumption by End-Users from 2016 to 2027

    • Table Northwest China Next-Generation Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Next-Generation Biologics Consumption Share by End-Users in 2016

    • Figure Northwest China Next-Generation Biologics Consumption Share by End-Users in 2021

    • Figure Northwest China Next-Generation Biologics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Molecular Partners

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Molecular Partners

    • Figure Sales and Growth Rate Analysis of Molecular Partners

    • Figure Revenue and Market Share Analysis of Molecular Partners

    • Table Product and Service Introduction of Molecular Partners

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Kyowa Hakko Kirin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kyowa Hakko Kirin

    • Figure Sales and Growth Rate Analysis of Kyowa Hakko Kirin

    • Figure Revenue and Market Share Analysis of Kyowa Hakko Kirin

    • Table Product and Service Introduction of Kyowa Hakko Kirin

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US